VAM
BIIB icon

Verity Asset Management’s Biogen BIIB Stock Holding History

Verity Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$245K Buy
+782
New +$232K 0.23% 90

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Verity Asset Management's BIIB Position: Q3 2016 in Review

Verity Asset Management opened a new position in Biogen (BIIB) in Q3 2016: 782 shares worth $245K. The stake represents 0.23% of the portfolio and ranks #90 among its holdings.

1,012 funds tracked by Wall St. Rank hold BIIB as of Q3 2016.

  • Verity Asset Management held 782 shares of Biogen worth $245K as of Q3 2016.
  • Biogen was a new Verity Asset Management position in Q3 2016.
  • Biogen made up 0.23% of Verity Asset Management's portfolio in Q3 2016, its #90 holding.
  • 1,012 funds tracked by Wall St. Rank held Biogen as of Q3 2016.

Based on Verity Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.